Undecylenic Acid Undecylenic acid is a less well-known treatment for topical Candida-related infections, but its becoming more popular
Parker LJ, Ciccone S, Italiano LC, Primavera A, Oakley AJ, Morton CJ, et al
They operate primarily under state oversight, with some federal requirements
their accumulation at presynaptic terminals and postsynaptic dendritic spines is increased when the synaptic activity is elevated [31]
According to the UK Summary of Product Characteristics (SmPC), the 300 mg dose should only be used in patients with an eGFR of 60 mL/min/1.73m or above
it is the ability to supply, price and sustain therapy at scale